News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,133 Results
Type
Article (249)
Company Profile (1)
Press Release (2883)
Section
Business (638)
Career Advice (8)
Deals (105)
Drug Delivery (2)
Drug Development (500)
Employer Resources (1)
FDA (142)
Job Trends (80)
News (1524)
Policy (346)
Tag
Academia (20)
Allergies (1)
Alliances (116)
ALS (1)
Alzheimer's disease (3)
Approvals (147)
Bankruptcy (1)
Best Places to Work (74)
BIOSECURE Act (4)
Biosimilars (1)
Biotechnology (1)
Bladder cancer (1)
Brain cancer (1)
Cancer (10)
Career advice (7)
CDC (1)
Cell therapy (4)
Clinical research (418)
Collaboration (7)
COVID-19 (32)
Cystic fibrosis (3)
Data (38)
Diabetes (4)
Diagnostics (18)
Diversity, equity & inclusion (1)
Drug discovery (1)
Drug pricing (4)
Duchenne muscular dystrophy (2)
Earnings (296)
Employer resources (1)
Events (401)
Executive appointments (1)
FDA (166)
Frontotemporal dementia (1)
Funding (6)
Gene therapy (3)
GLP-1 (2)
Government (61)
Guidances (3)
Healthcare (202)
Immunology and inflammation (3)
Indications (1)
Infectious disease (40)
Inflation Reduction Act (2)
Influenza (1)
IPO (53)
IRA (3)
Job creations (9)
Job search strategy (7)
Labor market (1)
Layoffs (4)
Legal (107)
Liver cancer (1)
Manufacturing (9)
Medical device (86)
Medtech (86)
Mergers & acquisitions (53)
Metabolic disorders (5)
Neurodegenerative disease (1)
Neuropsychiatric disorders (1)
Neuroscience (12)
NextGen: Class of 2026 (61)
Non-profit (56)
Obesity (1)
Opinion (5)
Parkinson's disease (1)
Patents (1)
Patient recruitment (3)
People (177)
Pharmacy benefit managers (2)
Phase 1 (80)
Phase 2 (165)
Phase 3 (201)
Pipeline (31)
Policy (9)
Postmarket research (22)
Preclinical (55)
Rare diseases (8)
Real estate (10)
Regulatory (208)
Reports (1)
Research institute (11)
RSV (7)
Schizophrenia (3)
Special edition (1)
Sponsored (1)
Startups (12)
Supply chain (2)
Vaccines (13)
Women's health (1)
Date
Last 7 days (4)
Last 30 days (9)
Last 365 days (111)
2026 (12)
2025 (118)
2024 (189)
2023 (200)
2022 (266)
2021 (281)
2020 (252)
2019 (272)
2018 (248)
2017 (166)
2016 (160)
2015 (169)
2014 (137)
2013 (82)
2012 (105)
2011 (89)
2010 (66)
Location
Africa (3)
Asia (122)
Australia (42)
California (30)
Canada (12)
China (4)
Connecticut (2)
Delaware (4)
Europe (328)
Florida (11)
Illinois (4)
Japan (4)
Louisiana (1)
Maryland (5)
Massachusetts (29)
Minnesota (2)
Nevada (1)
New Jersey (8)
New York (8)
North Carolina (3)
Northern California (14)
Ohio (1)
Oregon (1)
Pennsylvania (44)
South America (6)
Southern California (13)
Tennessee (1)
Texas (4)
United States (163)
Utah (1)
Washington D.C. (3)
Washington State (3)
Wisconsin (1)
3,133 Results for "passage bio.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Longeveron Applauds Passage of the Mikaela Naylon Give Kids a Chance Act and Reauthorization of Rare Pediatric Disease Priority Review Voucher Program
February 5, 2026
·
8 min read
Press Releases
Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference
November 5, 2025
·
1 min read
Press Releases
Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights
November 10, 2025
·
10 min read
Press Releases
Passage Bio to Participate in Chardan’s 9th Annual Genetic Medicines Conference
October 15, 2025
·
1 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference
August 29, 2025
·
1 min read
Press Releases
Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights
August 12, 2025
·
10 min read
Press Releases
Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update
June 23, 2025
·
8 min read
Press Releases
Passage Bio Reports First Quarter 2025 Financial Results and Provides Recent Business Highlights
May 14, 2025
·
8 min read
Press Releases
Passage Bio to Participate in Upcoming March 2025 Investor Conferences
February 27, 2025
·
1 min read
1 of 314
Next
